{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:47:34Z","timestamp":1792446454092,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BE 3246\/6-1"],"award-info":[{"award-number":["BE 3246\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GE 905\/24-1"],"award-info":[{"award-number":["GE 905\/24-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114673","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T11:08:58Z","timestamp":1625828938000},"page":"114673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Angiotensin II receptor type 1 \u2013 An update on structure, expression and pathology"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2810-5045","authenticated-orcid":false,"given":"Robert","family":"Eckenstaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Sandori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1581-8767","authenticated-orcid":false,"given":"Michael","family":"Gekle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-4521","authenticated-orcid":false,"given":"Ralf A.","family":"Benndorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0005","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/j.2040-4603.2014.tb00567.x","article-title":"Classical Renin-Angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr. Physiol."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2021.114673_b0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1113\/jphysiol.2003.049890","article-title":"Renin: origin, secretion and synthesis","volume":"552","author":"Persson","year":"2003","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00424-012-1115-x","article-title":"Tubular control of renin synthesis and secretion","volume":"465","author":"Schnermann","year":"2013","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2021.114673_b0020","first-page":"310","article-title":"Renin release","volume":"22","author":"Schweda","year":"2007","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.bcp.2021.114673_b0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10641963.2017.1377218","article-title":"Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease","volume":"40","author":"Hussain","year":"2018","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.bcp.2021.114673_b0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/5584_2016_84","article-title":"Hypertension in chronic kidney disease","volume":"956","author":"Hamrahian","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114673_b0045","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2018.12.063","article-title":"Effect of neprilysin inhibition on various natriuretic peptide assays","volume":"73","author":"Ibrahim","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114673_b0050","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","article-title":"B-type natriuretic peptide during treatment with sacubitril\/valsartan: the PARADIGM-HF trial","volume":"73","author":"Myhre","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0091270009343932","article-title":"Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)","volume":"50","author":"Gu","year":"2010","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114673_b0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2021.114673_b0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-90-481-9060-7_5","article-title":"Local RAS","volume":"690","author":"Leung","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0070","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2021.114673_b0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.phrs.2008.06.009","article-title":"Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats","volume":"58","author":"Li","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0080","doi-asserted-by":"crossref","first-page":"H849","DOI":"10.1152\/ajpheart.00422.2016","article-title":"Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries","volume":"311","author":"Flavahan","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114673_b0085","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.peptides.2011.06.018","article-title":"On the local cardiac renin angiotensin system. Basic and clinical implications","volume":"32","author":"De Mello","year":"2011","journal-title":"Peptides"},{"issue":"38","key":"10.1016\/j.bcp.2021.114673_b0090","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","article-title":"Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications","volume":"36","author":"M\u00fcnzel","year":"2015","journal-title":"Eur. Heart J."},{"issue":"36","key":"10.1016\/j.bcp.2021.114673_b0095","doi-asserted-by":"crossref","first-page":"14849","DOI":"10.1073\/pnas.1101507108","article-title":"Identification and characterization of a functional mitochondrial angiotensin system","volume":"108","author":"Abadir","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0100","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1470320313515039","article-title":"Nuclear expression of renin-angiotensin system components in NRK-52E renal epithelial cells","volume":"16","author":"Alzayadneh","year":"2015","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11906-009-0020-y","article-title":"The intracellular renin-angiotensin system in the heart","volume":"11","author":"Kumar","year":"2009","journal-title":"Curr. Hypertens. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MNH.0b013e3282f521a8","article-title":"The intracellular renin-angiotensin system: implications in cardiovascular remodeling","volume":"17","author":"Kumar","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0115","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00391.2007","article-title":"High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes","volume":"293","author":"Singh","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114673_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.439","article-title":"The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system","volume":"8","author":"Villar-Cheda","year":"2017","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0125","article-title":"Angiotensin receptors: structure, function, signaling and clinical applications","volume":"1","author":"Singh","year":"2016","journal-title":"J. Cell Signal"},{"issue":"10","key":"10.1016\/j.bcp.2021.114673_b0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2009.2","article-title":"Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice","volume":"75","author":"Benndorf","year":"2009","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1096\/fj.02-0321fje","article-title":"AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway","volume":"17","author":"Ritter","year":"2003","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0140","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.RES.0000088358.99466.04","article-title":"Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells","volume":"93","author":"Benndorf","year":"2003","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.bcp.2021.114673_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047916","article-title":"Impact of AT2 receptor deficiency on postnatal cardiovascular development","volume":"7","author":"Biermann","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.bcp.2021.114673_b0150","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.RES.0000019892.41157.24","article-title":"Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb","volume":"90","author":"Silvestre","year":"2002","journal-title":"Circ. Res."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2021.114673_b0155","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00005344-200111002-00003","article-title":"Molecular interactions of vasoactive systems in cardiovascular damage","volume":"38","author":"Bader","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114673_b0160","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","article-title":"The AT2 receptor\u2013a matter of love and hate","volume":"26","author":"Steckelings","year":"2005","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1470320309347787","article-title":"The angiotensin II type 2 receptor in renal disease","volume":"11","author":"Wenzel","year":"2010","journal-title":"J. Renin. Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.bcp.2021.114673_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110231","article-title":"COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight?","volume":"144","author":"Wiese","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"6965","key":"10.1016\/j.bcp.2021.114673_b0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0180","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ehjcvp\/pvaa053","article-title":"The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system","volume":"6","author":"Offringa","year":"2020","journal-title":"Eur. Heart J. Cardiovasc Pharmacother."},{"issue":"17","key":"10.1016\/j.bcp.2021.114673_b0190","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bcp.2021.114673_b0195","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","article-title":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors","volume":"47","author":"Vuille-dit-Bille","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2021.114673_b0210","doi-asserted-by":"crossref","unstructured":"M. Cahova, M. Kveton, V. Petr, D. Funda, H. Dankova, O. Viklicky, P. Hruba, Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors, Kidney Blood Press Res. 46(2) (2021) 245-249.","DOI":"10.1159\/000513710"},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0215","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2021.114673_b0220","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.yjmcc.2020.03.018","article-title":"An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations","volume":"141","author":"Wild","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/ATVBAHA.116.307787","article-title":"Mechanisms of Mas1 receptor-mediated signaling in the vascular endothelium","volume":"37","author":"Hoffmann","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bcp.2021.114673_b0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2018.06.007","article-title":"Angiotensin (1\u20137) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor","volume":"50","author":"Gaidarov","year":"2018","journal-title":"Cell. Signal."},{"issue":"7","key":"10.1016\/j.bcp.2021.114673_b0240","first-page":"1113","article-title":"Genetic analysis of the human type-1 angiotensin II receptor","volume":"6","author":"Curnow","year":"1992","journal-title":"Mol. Endocrinol."},{"issue":"1 Pt 2","key":"10.1016\/j.bcp.2021.114673_b0245","doi-asserted-by":"crossref","first-page":"31s","DOI":"10.1016\/S0895-7061(99)00249-6","article-title":"Localization and function of angiotensin AT1 receptors","volume":"13","author":"Allen","year":"2000","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1043-2760(02)00038-3","article-title":"Alternative splicing: a novel mechanism to fine-tune the expression and function of the human AT1 receptor","volume":"14","author":"Elton","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"issue":"Suppl 11","key":"10.1016\/j.bcp.2021.114673_b0255","first-page":"S23","article-title":"Localization of angiotensin AT1 and AT2 receptors","volume":"10","author":"Allen","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0260","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1994.1450","article-title":"The genomic organization of human angiotensin II type 1 receptor","volume":"200","author":"Guo","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0265","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0270","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1006\/bbrc.1994.2402","article-title":"Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung","volume":"203","author":"Koike","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0275","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/1470320310379065","article-title":"Developmental changes in AT1 and AT2 receptor-protein expression in rats","volume":"11","author":"Yu","year":"2010","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0280","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1172\/JCI115395","article-title":"Expression of AT2 receptors in the developing rat fetus","volume":"88","author":"Grady","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"6551","key":"10.1016\/j.bcp.2021.114673_b0285","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/377748a0","article-title":"Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor","volume":"377","author":"Ichiki","year":"1995","journal-title":"Nature"},{"issue":"6551","key":"10.1016\/j.bcp.2021.114673_b0290","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/377744a0","article-title":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice","volume":"377","author":"Hein","year":"1995","journal-title":"Nature"},{"issue":"Pt 1","key":"10.1016\/j.bcp.2021.114673_b0295","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/BJ20050189","article-title":"Importance of N-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the human AT1 receptor","volume":"390","author":"Lanctot","year":"2005","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0167-0115(95)00030-F","article-title":"Disulfide bridges in extracellular domains of angiotensin II receptor type IA","volume":"57","author":"Ohyama","year":"1995","journal-title":"Regul. Pept."},{"issue":"12","key":"10.1016\/j.bcp.2021.114673_b0305","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1074\/jbc.M112.442053","article-title":"Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode","volume":"288","author":"Fillion","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114673_b0310","article-title":"A guide to membrane protein X-ray crystallography","author":"Kermani","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2021.114673_b0315","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev-biophys-070317-033239","article-title":"Serial femtosecond crystallography of G protein-coupled receptors","volume":"47","author":"Stauch","year":"2018","journal-title":"Annu. Rev. Biophys."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0320","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41594-020-00554-6","article-title":"Cryo-EM structure of an activated GPCR-G protein complex in lipid nanodiscs","volume":"28","author":"Zhang","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0325","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cell.2015.04.011","article-title":"Structure of the angiotensin receptor revealed by serial femtosecond crystallography","volume":"161","author":"Zhang","year":"2015","journal-title":"Cell"},{"issue":"49","key":"10.1016\/j.bcp.2021.114673_b0330","doi-asserted-by":"crossref","first-page":"29127","DOI":"10.1074\/jbc.M115.689000","article-title":"Structural basis for ligand recognition and functional selectivity at angiotensin receptor","volume":"290","author":"Zhang","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"7650","key":"10.1016\/j.bcp.2021.114673_b0335","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature22035","article-title":"Structural basis for selectivity and diversity in angiotensin II receptors","volume":"544","author":"Zhang","year":"2017","journal-title":"Nature"},{"issue":"6480","key":"10.1016\/j.bcp.2021.114673_b0340","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1126\/science.aay9813","article-title":"Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR","volume":"367","author":"Wingler","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0345","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2018.12.005","article-title":"Angiotensin analogs with divergent bias stabilize distinct receptor conformations","volume":"176","author":"Wingler","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0350","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cell.2018.12.006","article-title":"Distinctive activation mechanism for angiotensin receptor revealed by a synthetic nanobody","volume":"176","author":"Wingler","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0355","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.str.2019.12.003","article-title":"The crystal structure of angiotensin II Type 2 receptor with endogenous peptide hormone","volume":"28","author":"Asada","year":"2020","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","article-title":"Allosteric sodium in class A GPCR signaling","volume":"39","author":"Katritch","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"51","key":"10.1016\/j.bcp.2021.114673_b0365","doi-asserted-by":"crossref","first-page":"16435","DOI":"10.1021\/bi961593m","article-title":"The active state of the AT1 angiotensin receptor is generated by angiotensin II induction","volume":"35","author":"Noda","year":"1996","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0370","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1074\/jbc.M211338200","article-title":"TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor","volume":"278","author":"Miura","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0375","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbamem.2006.09.001","article-title":"Lipid-protein interactions in GPCR-associated signaling","volume":"1768","author":"Escrib\u00e1","year":"2007","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0380","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1073\/pnas.0409532102","article-title":"Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0385","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/mol.54.6.935","article-title":"Agonist-induced phosphorylation of the angiotensin AT1a receptor is localized to a serine\/threonine-rich region of its cytoplasmic tail","volume":"54","author":"Smith","year":"1998","journal-title":"Mol. Pharmacol."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2021.114673_b0390","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/bj3430637","article-title":"Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor","volume":"343","author":"Qian","year":"1999","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.bcp.2021.114673_b0395","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/mend.12.10.0179","article-title":"Phosphorylation of the angiotensin II (AT1A) receptor carboxyl terminus: a role in receptor endocytosis","volume":"12","author":"Thomas","year":"1998","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114673_b0400","first-page":"1706","article-title":"Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization","volume":"15","author":"Qian","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2021.114673_b0405","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fendo.2019.00519","article-title":"The role of \u03b2-arrestin proteins in organization of signaling and regulation of the AT1 angiotensin receptor","volume":"10","author":"Turu","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0410","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1073\/pnas.041604898","article-title":"Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds","volume":"98","author":"Luttrell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.bcp.2021.114673_b0415","doi-asserted-by":"crossref","first-page":"9429","DOI":"10.1074\/jbc.M106457200","article-title":"beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation","volume":"277","author":"Tohgo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114673_b0420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coemr.2020.07.011","article-title":"Subcellular hot spots of GPCR signaling promote vascular inflammation","volume":"16","author":"Birch","year":"2021","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"34","key":"10.1016\/j.bcp.2021.114673_b0425","doi-asserted-by":"crossref","first-page":"25880","DOI":"10.1074\/jbc.C110.109421","article-title":"The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis","volume":"285","author":"McAllister-Lucas","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2021.114673_b0430","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4331\/wjbc.v1.i12.353","article-title":"CARMA3: A novel scaffold protein in regulation of NF-\u03baB activation and diseases","volume":"1","author":"Sun","year":"2010","journal-title":"World J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0435","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1124\/mol.114.097337","article-title":"Characterization of angiotensin II molecular determinants involved in AT1 receptor functional Selectivity","volume":"87","author":"Domazet","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114673_b0440","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.tcb.2020.06.002","article-title":"Conformational basis of G protein-coupled receptor signaling versatility","volume":"30","author":"Wingler","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0445","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/mol.111.072801","article-title":"Quantifying ligand bias at seven-transmembrane receptors","volume":"80","author":"Rajagopal","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0450","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","article-title":"Therapeutic potential of \u03b2-arrestin- and G protein-biased agonists","volume":"17","author":"Whalen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2021.114673_b0455","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2017.06.013","article-title":"Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism","volume":"123","author":"Takezako","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"Pt A","key":"10.1016\/j.bcp.2021.114673_b0460","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0465","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0952-3278(97)90003-X","article-title":"Protein kinase C mediates angiotensin II-induced contractions and the release of endothelin and prostacyclin in rat aortic rings","volume":"57","author":"Oriji","year":"1997","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0470","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006023","article-title":"Signaling in muscle contraction","volume":"7","author":"Kuo","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"31","key":"10.1016\/j.bcp.2021.114673_b0475","doi-asserted-by":"crossref","first-page":"19772","DOI":"10.1074\/jbc.273.31.19772","article-title":"Temporal dispersion of activation of phospholipase C-beta1 and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq\/11, alpha12, and beta gamma G protein subunits","volume":"273","author":"Ushio-Fukai","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0480","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/HYPERTENSIONAHA.114.05065","article-title":"Angiotensin II activates the RhoA exchange factor Arhgef1 in humans","volume":"65","author":"Carbone","year":"2015","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0485","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/ajh\/hpz176","article-title":"Downregulation of Brain G\u03b112 Attenuates Angiotensin II-Dependent Hypertension","volume":"33","author":"Gao","year":"2020","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0490","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.108.188524","article-title":"ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells","volume":"104","author":"Wang","year":"2009","journal-title":"Circ. Res."},{"issue":"1\u20134","key":"10.1016\/j.bcp.2021.114673_b0495","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1152\/advances.2003.27.4.201","article-title":"Smooth muscle contraction and relaxation","volume":"27","author":"Webb","year":"2003","journal-title":"Adv. Physiol. Educ."},{"issue":"11","key":"10.1016\/j.bcp.2021.114673_b0500","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.RES.0000105920.33926.60","article-title":"Cellular mechanism of vasoconstriction induced by angiotensin II: it remains to be determined","volume":"93","author":"Kanaide","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2021.114673_b0505","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2741\/3289","article-title":"The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor","volume":"14","author":"Porrello","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0510","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/HYPERTENSIONAHA.113.01543","article-title":"Dietary salt intake regulates WNK3-SPAK-NKCC1 phosphorylation cascade in mouse aorta through angiotensin II","volume":"62","author":"Zeniya","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2021.114673_b0515","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yjmcc.2015.02.020","article-title":"Overexpression of ANO1\/TMEM16A, an arterial Ca2+-activated Cl- channel, contributes to spontaneous hypertension","volume":"82","author":"Wang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0520","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.32.3.488","article-title":"Role of NADH\/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy","volume":"32","author":"Zafari","year":"1998","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0525","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0530","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.RES.0000033523.08033.16","article-title":"Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators","volume":"91","author":"Seshiah","year":"2002","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.bcp.2021.114673_b0535","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0540","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.ATV.0000069236.27911.68","article-title":"c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells","volume":"23","author":"Touyz","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0545","first-page":"573","article-title":"Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats","volume":"51","author":"De Cavanagh","year":"2005","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2021.114673_b0550","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-0115(00)00105-1","article-title":"Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors","volume":"90","author":"Dimmeler","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bcp.2021.114673_b0555","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.566410","article-title":"Angiotensin II decreases endothelial nitric oxide synthase phosphorylation via AT(1)R Nox\/ROS\/PP2A pathway","volume":"11","author":"Ding","year":"2020","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0560","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/CIRCULATIONAHA.109.883777","article-title":"Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction","volume":"121","author":"Silberman","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0565","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010187","article-title":"New therapeutic implications of endothelial nitric oxide synthase (eNOS) function\/dysfunction in cardiovascular disease","volume":"20","author":"Daiber","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2021.114673_b0570","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.ATV.0000168896.64927.bb","article-title":"Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase","volume":"25","author":"M\u00fcnzel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0575","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","article-title":"Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?","volume":"140","author":"Rochette","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"5\u20136","key":"10.1016\/j.bcp.2021.114673_b0580","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vph.2012.02.004","article-title":"Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases","volume":"57","author":"Roe","year":"2012","journal-title":"Vasc.Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0585","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157016112798829760","article-title":"The role of nitric oxide on endothelial function","volume":"10","author":"Tousoulis","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114673_b0590","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.RES.81.6.970","article-title":"Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide","volume":"81","author":"Dimmeler","year":"1997","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0595","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.ATV.20.3.645","article-title":"Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress","volume":"20","author":"Pueyo","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"15","key":"10.1016\/j.bcp.2021.114673_b0600","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.CIR.100.15.1646","article-title":"Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo","volume":"100","author":"Pastore","year":"1999","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.bcp.2021.114673_b0605","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000015603.84788.47","article-title":"Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway","volume":"105","author":"Kalra","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0610","first-page":"H786","article-title":"Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation","volume":"276","author":"Li","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0615","doi-asserted-by":"crossref","first-page":"C779","DOI":"10.1152\/ajpcell.00398.2003","article-title":"Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha","volume":"286","author":"Arenas","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114673_b0620","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0625","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/HYPERTENSIONAHA.118.11184","article-title":"PARP-1 (Poly[ADP-Ribose] polymerase 1) inhibition protects from Ang II (Angiotensin II)-induced abdominal aortic aneurysm in mice","volume":"72","author":"Liang","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0630","doi-asserted-by":"crossref","first-page":"H1660","DOI":"10.1152\/ajpheart.00028.2009","article-title":"ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice","volume":"296","author":"Cassis","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0635","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11906-008-0020-3","article-title":"The role of the renin-angiotensin system in aortic aneurysmal diseases","volume":"10","author":"Lu","year":"2008","journal-title":"Curr. Hypertens. Rep."},{"issue":"28","key":"10.1016\/j.bcp.2021.114673_b0640","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.2174\/1381612821666150826093318","article-title":"Angiotensin II and abdominal aortic aneurysms: an update","volume":"21","author":"Liu","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0645","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.regpep.2006.07.011","article-title":"Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat","volume":"138","author":"Li","year":"2007","journal-title":"Regul. Pept."},{"issue":"12","key":"10.1016\/j.bcp.2021.114673_b0650","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.freeradbiomed.2005.08.006","article-title":"Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes","volume":"39","author":"Wu","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"22","key":"10.1016\/j.bcp.2021.114673_b0655","doi-asserted-by":"crossref","first-page":"15099","DOI":"10.1074\/jbc.M600200200","article-title":"Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin","volume":"281","author":"Chandrasekar","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0660","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.80.1.139","article-title":"Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats","volume":"80","author":"Kudoh","year":"1997","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0665","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1254\/jjp.80.97","article-title":"Activation of mitogen-activated protein kinases in cardiovascular hypertrophy and remodeling","volume":"80","author":"Kim","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114673_b0670","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev-pharmtox-070115-095427","article-title":"Epidermal growth factor receptor transactivation: mechanisms, pathophysiology, and potential therapies in the cardiovascular system","volume":"56","author":"Forrester","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0675","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.mnh.0000441152.62943.29","article-title":"Role of epidermal growth factor receptor in vascular structure and function","volume":"23","author":"Schreier","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0680","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/CS20150503","article-title":"Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action","volume":"130","author":"Schreier","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.bcp.2021.114673_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2013.05.005","article-title":"ADAM17 silencing by adenovirus encoding miRNA-embedded siRNA revealed essential signal transduction by angiotensin II in vascular smooth muscle cells","volume":"62","author":"Elliott","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114673_b0690","doi-asserted-by":"crossref","first-page":"C776","DOI":"10.1152\/ajpcell.00145.2019","article-title":"Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT(1)R\/ROS\/p38 MAPK\/ADAM17 pathway","volume":"317","author":"Zhang","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2 Pt 2","key":"10.1016\/j.bcp.2021.114673_b0695","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/hy02t2.102909","article-title":"Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"39","author":"Touyz","year":"2002","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0700","doi-asserted-by":"crossref","first-page":"F858","DOI":"10.1152\/ajprenal.00282.2003","article-title":"H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1\/2, but not Akt, activation in renal cells","volume":"286","author":"Zhuang","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"18","key":"10.1016\/j.bcp.2021.114673_b0705","doi-asserted-by":"crossref","first-page":"11953","DOI":"10.1074\/jbc.M808176200","article-title":"Independent beta-arrestin2 and Gq\/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor","volume":"284","author":"Kim","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114673_b0710","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"issue":"15","key":"10.1016\/j.bcp.2021.114673_b0715","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1074\/jbc.273.15.8890","article-title":"Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells","volume":"273","author":"Eguchi","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114673_b0720","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jcp.20967","article-title":"ANG II-stimulated DNA synthesis is mediated by ANG II receptor-dependent Ca(2+)\/PKC as well as EGF receptor-dependent PI3K\/Akt\/mTOR\/p70S6K1 signal pathways in mouse embryonic stem cells","volume":"211","author":"Han","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"6528","key":"10.1016\/j.bcp.2021.114673_b0725","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/375247a0","article-title":"Direct stimulation of Jak\/STAT pathway by the angiotensin II AT1 receptor","volume":"375","author":"Marrero","year":"1995","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2021.114673_b0730","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20202388","article-title":"Angiotensin II enhances the proliferation of Natural Killer\/T-cell lymphoma cells via activating PI3K\/Akt signaling pathway","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bcp.2021.114673_b0735","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2017.04.014","article-title":"Dihydromyricetin attenuated Ang II induced cardiac fibroblasts proliferation related to inhibitory of oxidative stress","volume":"807","author":"Song","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0740","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1016-8478(23)13226-2","article-title":"Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway","volume":"20","author":"Yang","year":"2005","journal-title":"Mol. Cells"},{"issue":"12","key":"10.1016\/j.bcp.2021.114673_b0745","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1139\/Y09-089","article-title":"Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells","volume":"87","author":"Gomez Sandoval","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114673_b0750","doi-asserted-by":"crossref","first-page":"13209","DOI":"10.1074\/jbc.M509771200","article-title":"A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation","volume":"281","author":"Yahata","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2021.114673_b0755","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.0000030181.63741.56","article-title":"Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense","volume":"106","author":"Kagiyama","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bcp.2021.114673_b0760","first-page":"474","article-title":"Curcumin suppress cardiac fibroblasts activities by regulating proliferation, migration, and the extracellular matrix","volume":"30","author":"Chung","year":"2014","journal-title":"Acta Cardiol. Sin."},{"issue":"2","key":"10.1016\/j.bcp.2021.114673_b0765","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1681\/ASN.2011121178","article-title":"A look at transactivation of the EGF receptor by angiotensin II","volume":"23","author":"Okada","year":"2012","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:48:22Z","timestamp":1777391302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221002860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":153,"alternative-id":["S0006295221002860"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114673","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II receptor type 1 \u2013 An update on structure, expression and pathology","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114673"}}